Nerx Biosciences
UEI: PZ6HDAKNKXY9
• CAGE: 668Y4
Overview
Awardee Type
Parent
Company Description
NĒRx BioSciences Inc is a company dedicated to the discovery and development of targeted therapeutics for cancer. Formed in 2009, we specialize in the discovery and early development of novel biopharmaceutical compounds.
Name
Nerx Biosciences
Website
Headquarters
Indianapolis, IN
United States
United States
Most Recent Award
Aug. 1, 2024
Calculating
Federal grant recipient
NERX BIOSCIENCES INC
(UEI PZ6HDAKNKXY9, CAGE 668Y4)
is headquartered in Indianapolis IN.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in July 2009 and
federally registered in
October 2010.
Federal Award Analysis
Nerx Biosciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NERX BIOSCIENCES INC
UEI
PZ6HDAKNKXY9
CAGE Code
668Y4
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 1, 2009
Initial Registration
Oct. 25, 2010
Last Registration
Feb. 14, 2025
Registration Activation
Feb. 14, 2025
Registration Expiration
Feb. 12, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Subchapter S Corporation
Subchapter S Corporation
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No